Cargando…
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort
Bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) is a recommended once-daily single tablet regimen for the treatment of people living with HIV-1 (PLWH). We aimed to assess efficacy, safety and tolerability of BIC/FTC/TAF among PLWH, with a specific focus on people older than 55...
Autores principales: | Lazzaro, Alessandro, Cacciola, Elio Gentilini, Borrazzo, Cristian, Innocenti, Giuseppe Pietro, Cavallari, Eugenio Nelson, Mezzaroma, Ivano, Falciano, Mario, Fimiani, Caterina, Mastroianni, Claudio Maria, Ceccarelli, Giancarlo, d’Ettorre, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774414/ https://www.ncbi.nlm.nih.gov/pubmed/35054243 http://dx.doi.org/10.3390/diagnostics12010076 |
Ejemplares similares
-
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort
por: Lazzaro, Alessandro, et al.
Publicado: (2023) -
Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience
por: Russo, Alessandro, et al.
Publicado: (2021) -
Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2019) -
Health-related quality of life in survivors of severe COVID-19 infection
por: d’Ettorre, Gabriele, et al.
Publicado: (2022) -
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone
por: Russo, Alessandro, et al.
Publicado: (2022)